Surendar Raj

Territory Business Executive @Novartis India

Chennai, IN

Driving Innovation in Lipid Management with Sybrava (Inclisiran)Currently working with Sybrava (Inclisiran) – the world’s first and only siRNA therapy for aggressive LDL-C reduction – I’ve been at the forefront of introducing cutting-edge lipid-lowering solutions to high-risk cardiovascular patients.Leveraging strong existing relationships with key stakeholders, I successfully achieved a major breakthrough at Southern Railway Hospital, expanding access to this novel therapy. Additionally, I opened a new government account at ECHS Hospital, utilizing its network of empanelled hospitals to reach a wider beneficiary base. Highlights: Introduced Sybrava in strategic government institutions Re-engaged key accounts through trusted stakeholder relationships Opened new access pathways via empanelled networks Positively impacted treatment outcomes for a large patient populationProud to be part of a mission that brings groundbreaking therapies to the people who need them most.